Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $716.2100 (-0.93%) ($710.6000 - $725.8300) on Tue. Apr. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.46% (three month average) | RSI | 58 | Latest Price | $716.2100(-0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) DIA(41%) IWD(39%) XLV(39%) SPY(38%) | Factors Impacting REGN price | REGN will decline at least -0.73% in a week (0% probabilities). VIXM(-19%) TBT(-13%) UUP(-8%) VXX(-3%) USO(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.73% (StdDev 1.46%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $723.71(-1.04%) | 10 Day Moving Average | $720.74(-0.63%) | 20 Day Moving Average | $706.15(1.42%) | To recent high | -3.1% | To recent low | 18.8% | Market Cap | $75.939b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |